In a trial of 4,877 patients in Taiwan, HLA-B*1502 genotyping completely prevented SJS/TEN from occurring, while the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (61). The gene discussed is HLA-B; the disease is toxic epidermal necrolysis.